The Respiratory Panel 9 Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify a range of respiratory pathogens that can cause infections in patients. With a cost of 3280 AED, this panel test is utilized to quickly detect the presence of nine different respiratory viruses and bacteria, aiding in the accurate diagnosis and appropriate treatment of respiratory illnesses. The test involves collecting a sample from the patient, typically through a nasal or throat swab, which is then analyzed in the laboratory using advanced molecular techniques. This allows for the simultaneous detection of multiple pathogens, making it an efficient and effective method for diagnosing respiratory infections. By identifying the specific cause of a patient's symptoms, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes.
Duchenne and Becker Muscular Dystrophy (DMD/BMD) are genetic disorders characterized by progressive muscle degeneration and weakness. They are caused by mutations in the dystrophin gene, which is essential for maintaining muscle cell structure. The severity and onset of these conditions vary; DMD typically presents in early childhood and progresses more rapidly, while BMD has a later onset and a slower progression.
The DMD/BMD Gene Mutation Test is a crucial diagnostic tool used to detect mutations in the dystrophin gene. This test can confirm a diagnosis of Duchenne or Becker Muscular Dystrophy, helping to distinguish between the two based on the specific genetic alterations identified. It involves analyzing the patient's DNA, usually obtained through a blood sample, to identify any mutations in the dystrophin gene that are known to cause these conditions.
DNA Labs UAE offers this comprehensive genetic testing service for DMD/BMD. The test is priced at 3280 AED, reflecting the advanced technology and expertise required to accurately identify the wide range of possible mutations within the dystrophin gene. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into the specific genetic underpinnings of the condition, which can guide treatment decisions, provide information on the risk of recurrence in future pregnancies, and offer a clearer prognosis.
In summary, the DMD/BMD Gene Mutation Test available at DNA Labs UAE is a specialized diagnostic tool with a cost of 3280 AED, designed to detect the specific genetic mutations responsible for Duchenne and Becker Muscular Dystrophy. This test plays a critical role in the accurate diagnosis and management of these challenging conditions.
The FISH (Fluorescence In Situ Hybridization) for Her-2 Neu Test is a sophisticated diagnostic procedure used to assess the presence of the HER2 gene in breast cancer cells. This gene can play a significant role in the development and progression of breast cancer, and its detection is crucial for determining the most effective treatment plan for patients. The test involves using fluorescent probes to visualize the HER2 gene directly within the cancer cells, providing a clear indication of gene amplification.
At DNA Labs UAE, this test is meticulously conducted in a state-of-the-art laboratory setting by skilled professionals who specialize in genetic and molecular diagnostics. The cost of the FISH for Her-2 Neu Test at DNA Labs UAE is 2800 AED, reflecting the advanced technology and expertise required to perform this intricate analysis. This investment in testing can be vital for patients with breast cancer, as it helps in tailoring personalized treatment strategies that can significantly improve outcomes.
The Spinal Muscular Atrophy (SMA) Carrier Detection Test is a crucial genetic screening tool offered by DNA Labs UAE, designed to identify individuals who carry a mutation in the SMN1 gene, which is linked to Spinal Muscular Atrophy. SMA is a genetic disorder characterized by the loss of motor neurons in the spinal cord, leading to muscle weakness and atrophy. Carriers of the mutation do not typically show symptoms of SMA but have a chance of passing the gene to their offspring, making this test particularly important for those planning to start a family.
Priced at 2800 AED, the test involves a simple and non-invasive procedure, usually a blood sample or a cheek swab, to collect DNA for analysis. The process aims to provide prospective parents with valuable information regarding their carrier status, enabling them to make informed decisions about family planning and access to early interventions or therapies for affected children. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test stands as a proactive step towards managing the potential transmission of Spinal Muscular Atrophy, emphasizing the lab's commitment to leveraging genetic insights for better health outcomes.
The Spinal Muscular Atrophy (SMA) Mutation Detection Test is a crucial diagnostic tool used to identify the presence of genetic mutations responsible for Spinal Muscular Atrophy, a severe genetic disorder that affects the control of muscle movement. This test is specifically designed to detect mutations in the SMN1 gene, which are indicative of SMA. Conducted at DNA Labs UAE, a leading facility in genetic testing, this test plays a vital role in early diagnosis, allowing for timely intervention and management of the condition. The cost of the test is 2800 AED, reflecting the sophisticated technology and expertise required to accurately identify the mutations associated with SMA. Early detection through this test can significantly impact the treatment options and quality of life for individuals affected by Spinal Muscular Atrophy.
The Acute Leukemia Panel Test is a sophisticated diagnostic procedure designed to identify and classify acute leukemia, a rapid-onset cancer affecting the blood and bone marrow. This test is crucial for determining the specific type of leukemia, which can significantly influence treatment decisions and prognosis. By analyzing genetic markers and abnormalities associated with leukemia, the panel provides comprehensive insights that are vital for tailoring patient-specific therapeutic approaches.
Conducted at DNA Labs UAE, a leading facility known for its state-of-the-art technology and expert medical professionals, the test ensures accuracy and reliability. The cost of the Acute Leukemia Panel Test is 2800 AED, reflecting the intricate analysis and detailed information it provides. This investment can be invaluable for patients and healthcare providers alike, offering a foundation for targeted treatment plans and improved outcomes in the battle against acute leukemia.
The Chronic Leukemia Panel Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to assist in the detection and characterization of chronic leukemia, a type of cancer that affects the blood and bone marrow. This comprehensive panel test aims to identify specific genetic mutations and abnormalities associated with various forms of chronic leukemia, such as Chronic Myeloid Leukemia (CML) and Chronic Lymphocytic Leukemia (CLL). By analyzing a patient's genetic material, the test provides valuable insights that can guide personalized treatment strategies and prognostic assessments.
Priced at 2700 AED, the Chronic Leukemia Panel Test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high standards of accuracy and reliability. The test is particularly beneficial for patients diagnosed with or suspected of having chronic leukemia, offering a detailed genetic profile that can influence treatment decisions and management approaches. DNA Labs UAE employs cutting-edge technology and expertise to deliver comprehensive and actionable results, making the Chronic Leukemia Panel Test a crucial step in the journey towards effective leukemia care and management.
The "Microarray 60K POC Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to analyze a broad spectrum of genetic markers. This test utilizes microarray technology to examine over 60,000 points of interest within an individual's DNA. It's particularly useful in understanding genetic predispositions, identifying specific conditions, or determining the cause of unexplained symptoms. Given its comprehensive nature, the test can be a powerful resource in personalized medicine, allowing for tailored treatment plans based on genetic makeup.
The cost of the Microarray 60K POC Test is 2,700 AED. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test is performed under the guidance of experienced professionals. Patients opting for this test can expect a detailed analysis of their genetic data, which can be instrumental in guiding healthcare decisions. Whether for preventative measures, diagnostic purposes, or research, the Microarray 60K POC Test provides valuable insights into one's genetic health profile.
The NPM1 and CEBPA Test is a specialized genetic test designed to identify mutations in the NPM1 and CEBPA genes. These mutations are significant markers in diagnosing and prognosticating acute myeloid leukemia (AML), a type of cancer that affects the bone marrow and blood. By analyzing these specific genetic alterations, healthcare professionals can tailor treatment strategies more effectively, offering targeted therapies that can lead to better outcomes for patients.
The test is conducted at DNA Labs UAE, a reputable facility known for its state-of-the-art technology and expertise in genetic testing. The cost of the NPM1 and CEBPA Test at DNA Labs UAE is 2700 AED. This investment in testing can provide crucial information for the management of AML, guiding both diagnosis and treatment plans in a more personalized manner.
Plasmacytosis Test at DNA Labs UAE
The Plasmacytosis Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to measure the levels of plasma cells in the blood. Plasma cells are a type of white blood cell that plays a crucial role in the immune system by producing antibodies to fight off infections. However, an abnormal increase in plasma cells can be indicative of various medical conditions, including multiple myeloma, a type of blood cancer, or other plasma cell disorders.
At DNA Labs UAE, the test is conducted with precision and accuracy, employing the latest technology and methodologies to ensure reliable results. The cost of the Plasmacytosis Test is 2700 AED, reflecting the comprehensive nature of the analysis and the state-of-the-art facilities used in the process.
Individuals undergoing this test at DNA Labs UAE can expect a thorough examination of their blood sample, with results providing critical insights into their plasma cell levels. This information is vital for diagnosing conditions related to abnormal plasma cell production, enabling healthcare providers to formulate appropriate treatment plans.
DNA Labs UAE is renowned for its commitment to excellence in diagnostic services, making it a trusted choice for patients seeking advanced testing solutions, including the Plasmacytosis Test.
